Consensus Guidelines for Periprocedural Management of Coagulation Status and Hemostasis Risk in Percutaneous Image-guided Interventions

Patel, Indravadan; Davidson, J.; Nikolic, Boris; Salazar, Gloria M.; Schwartzberg, Marc S.; Walker, T.G.; Saad, Wael A.

doi:10.1016/j.jvir.2012.02.012

Cited by 599 publications

(345 citation statements)

References 82 publications

Supporting

Mentioning

330

Contrasting

Unclassified

Order By: Relevance

“…Anticoagulation and/or antiplatelet drugs should be discontinued at least 10 days before percutaneous ablation [41]. Warfarin should be discontinued 5 days before treatment and may be restarted 24 h after pulmonary ablation [3].…”

Section: Contraindicationsmentioning

confidence: 99%

Standards of Practice: Guidelines for Thermal Ablation of Primary and Secondary Lung Tumors

Pereira

Salvatore²

2012

Cardiovasc Intervent Radiol

View full text Add to dashboard Cite

Section: Contraindicationsmentioning

confidence: 99%

Standards of Practice: Guidelines for Thermal Ablation of Primary and Secondary Lung Tumors

Pereira

Salvatore²

2012

Cardiovasc Intervent Radiol

View full text Add to dashboard Cite

“…If the patient is taking an anticoagulant or antithrombotic, stopping the medication for 3 -10 days is recommended before and after US-FNA (4,5,9,11,17,18). However, performing US-FNA in patients taking anticoagulant or antithrombotic remains controversial and lacking in evidence, such as randomized controlled study (2,4,7,9,16,33). A recent study of 593 patients who underwent US-FNA on a total of 788 neck lesions reported no significant differ- ences in hematoma formation between patients who were on antithrombotic medications and those who were not (16).…”

Section: Discussionmentioning

confidence: 99%

Contributory Factors to Hemorrhage After Ultrasound-Guided Fine Needle Aspiration of Thyroid Nodules with an Emphasis on Patients Taking Antithrombotic or Anticoagulant Medications

et al. 2018

View full text Add to dashboard Cite

Background: Thyroid nodules are a common clinical problem and ultrasound-guided fine needle aspiration (US-FNA) biopsy is widely used for evaluation of thyroid nodules. However, few studies have addressed the contributing factors to hemorrhage after US-FNA of thyroid nodules. Objectives: To assess the contributory factors related to patient characteristics, ultrasound (US) features of the thyroid nodules, and the US-FNA procedures to affect hemorrhage complications after US-FNA of thyroid nodules. Methods: Between March 2014 and April 2015, 366 consecutive patients who underwent US-FNA of thyroid nodules were enrolled in this retrospective study. The characteristics of hematomas, including the location, maximum size, and clinical course, were assessed. The relationships between hematomas and factors related to the medical characteristics of patients, US characteristics of the nodules, and FNA procedural factors were analyzed. Results: Data on 365 nodules in 321 patients who underwent US-FNA of thyroid nodules were analyzed. Minor hemorrhagic complications developed in 14 (3.8%) of the 365 nodules. There were no statistically significant differences between patients taking or not taking an anticoagulant or antithrombotic (P = 0.270). Factors related to increased risk of hematoma were male sex (P = 0.031), larger maximum size (P = 0.002), a cystic or predominantly cystic nodule (P < 0.0001), a probable benign nodule (P < 0.0001), thicker needle size (P < 0.0001), and a greater number of the needle passes (P = 0.005). Conclusions: US-FNA can be performed safely even in patients taking anticoagulant or antithrombotic agents. Factors related to hemorrhagic complications are male sex, larger nodules, cystic or predominantly cystic nodules, probably benign nodules, thicker needles and a greater number of needle passes.

show abstract

“…Anticoagulation and antiplatelet drugs have to be ceased at least 5 days prior to the intervention. The following values are recommended by the consensus guidelines for the periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions: INR< 1.5; aPTT> 1.5x control if heparin is administered; and platelet count> 50 000 [41].…”

Section: Ablation Techniquementioning

confidence: 99%

Thermal Ablation of Lung Tumors: Focus on Microwave Ablation

Vogl

Nour-Eldin

Albrecht

et al. 2017

Fortschr Röntgenstr

View full text Add to dashboard Cite

show abstract

Consensus Guidelines for Periprocedural Management of Coagulation Status and Hemostasis Risk in Percutaneous Image-guided Interventions

Cited by 599 publications

References 82 publications

Standards of Practice: Guidelines for Thermal Ablation of Primary and Secondary Lung Tumors

Standards of Practice: Guidelines for Thermal Ablation of Primary and Secondary Lung Tumors

Contributory Factors to Hemorrhage After Ultrasound-Guided Fine Needle Aspiration of Thyroid Nodules with an Emphasis on Patients Taking Antithrombotic or Anticoagulant Medications

Thermal Ablation of Lung Tumors: Focus on Microwave Ablation

Contact Info

Product

Resources

About